BIOMAT Database Logo BIOMAT Database Logo

New virginiamycin M1 derivatives: synthesis, cholecystokinin binding inhibitory and antimicrobial properties. 1993

Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Merck Research Laboratories, Rahway, New Jersey 07065.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D011949 Receptors, Cholecystokinin Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood. CCK Receptors,Caerulein Receptors,Cholecystokinin Octapeptide Receptors,Cholecystokinin Receptors,Pancreozymin Receptors,Receptors, CCK,Receptors, Caerulein,Receptors, Pancreozymin,Receptors, Sincalide,Sincalide Receptors,CCK Receptor,CCK-4 Receptors,CCK-8 Receptors,Cholecystokinin Receptor,Receptors, CCK-4,Receptors, CCK-8,Receptors, Cholecystokinin Octapeptide,CCK 4 Receptors,CCK 8 Receptors,Octapeptide Receptors, Cholecystokinin,Receptor, CCK,Receptor, Cholecystokinin,Receptors, CCK 4,Receptors, CCK 8
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014769 Virginiamycin A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry. Staphylomycin,Antibiotic 899,Eskalin,Founderguard,Stajac,Virgimycine

Related Publications

Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Surface properties of new virginiamycin M(1) derivatives.
March 2009, Colloids and surfaces. B, Biointerfaces,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
The conformation of acetylated virginiamycin M1 and virginiamycin M1 in explicit solvents.
May 2007, Biochimica et biophysica acta,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
September 2011, European journal of medicinal chemistry,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives.
December 2022, International journal of molecular sciences,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
New trifluoromethyl quinolone derivatives: synthesis and investigation of antimicrobial properties.
June 2013, Bioorganic & medicinal chemistry letters,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
May 1996, Farmaco (Societa chimica italiana : 1989),
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Quinolone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
May 1996, Farmaco (Societa chimica italiana : 1989),
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Design, synthesis and cholinesterase inhibitory properties of new oxazole benzylamine derivatives.
December 2020, Journal of enzyme inhibition and medicinal chemistry,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Synthesis and antimicrobial properties of new chitosan derivatives containing guanidinium groups.
August 2020, Carbohydrate polymers,
Y K Lam, and P Dai, and D L Zink, and A J Smith, and N W Lee, and S Freedman, and M J Salvatore
Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
October 2009, European journal of medicinal chemistry,
Copied contents to your clipboard!